Ding Lina, Zhao Yang, Warren Christopher L, Sullivan Ruth, Eliceiri Kevin W, Shull James D
McArdle Laboratory for Cancer Research, Department of Oncology, School of Medicine and Public Health, University of Wisconsin Madison, 1400 University Avenue, Madison, WI 53706, USA.
BMC Cancer. 2013 Dec 5;13:573. doi: 10.1186/1471-2407-13-573.
We are using ACI and BN rats, which differ markedly in their susceptibility to 17β-estradiol (E2)-induced mammary cancer, to identify genetic variants and environmental factors that determine mammary cancer susceptibility. The objective of this study was to characterize the cellular and molecular responses to E2 in the mammary glands of ACI and BN rats to identify qualitative and quantitative phenotypes that associate with and/or may confer differences in susceptibility to mammary cancer.
Female ACI and BN rats were treated with E2 for 1, 3 or 12 weeks. Mammary gland morphology and histology were examined by whole mount and hematoxylin and eosin (H&E) staining. Cell proliferation and epithelial density were evaluated by quantitative immunohistochemistry. Apoptosis was evaluated by quantitative western blotting and flow cytometry. Mammary gland differentiation was examined by immunohistochemistry. Gene expression was evaluated by microarray, qRT-PCR and quantitative western blotting assays. Extracellular matrix (ECM) associated collagen was evaluated by Picrosirius Red staining and Second Harmonic Generation (SHG) microscopy.
The luminal epithelium of ACI rats exhibited a rapid and sustained proliferative response to E2. By contrast, the proliferative response exhibited by the mammary epithelium of BN rats was restrained and transitory. Moreover, the epithelium of BN rats appeared to undergo differentiation in response to E2, as evidenced by production of milk proteins as well as luminal ectasia and associated changes in the ECM. Marked differences in expression of genes that encode proteins with well-defined roles in mammary gland development (Pgr, Wnt4, Tnfsf11, Prlr, Stat5a, Areg, Gata3), differentiation and milk production (Lcn2, Spp1), regulation of extracellular environment (Mmp7, Mmp9), and cell-cell or cell-ECM interactions (Cd44, Cd24, Cd52) were observed.
We propose that these cellular and molecular phenotypes are heritable and may underlie, at least in part, the differences in mammary cancer susceptibility exhibited by ACI and BN rats.
我们正在使用对17β-雌二醇(E2)诱导的乳腺癌易感性存在显著差异的ACI和BN大鼠,以确定决定乳腺癌易感性的基因变异和环境因素。本研究的目的是表征ACI和BN大鼠乳腺中对E2的细胞和分子反应,以确定与乳腺癌易感性差异相关和/或可能导致该差异的定性和定量表型。
对雌性ACI和BN大鼠用E2处理1、3或12周。通过整装片以及苏木精和伊红(H&E)染色检查乳腺形态和组织学。通过定量免疫组织化学评估细胞增殖和上皮密度。通过定量蛋白质免疫印迹法和流式细胞术评估细胞凋亡。通过免疫组织化学检查乳腺分化。通过微阵列、qRT-PCR和定量蛋白质免疫印迹分析评估基因表达。通过天狼星红染色和二次谐波产生(SHG)显微镜评估细胞外基质(ECM)相关胶原蛋白。
ACI大鼠的管腔上皮对E2表现出快速且持续的增殖反应。相比之下,BN大鼠乳腺上皮表现出的增殖反应受到抑制且是短暂的。此外,BN大鼠的上皮似乎因E2而发生分化,乳汁蛋白的产生以及管腔扩张和ECM的相关变化证明了这一点。观察到在乳腺发育(Pgr、Wnt4,、Tnfsf11、Prlr、Stat5a、Areg、Gata3)、分化和乳汁产生(Lcn2、Spp1)、细胞外环境调节(Mmp7、Mmp9)以及细胞-细胞或细胞-ECM相互作用(Cd44、Cd24、Cd52)中具有明确作用的蛋白质编码基因的表达存在显著差异。
我们提出这些细胞和分子表型是可遗传的,并且可能至少部分地是ACI和BN大鼠所表现出的乳腺癌易感性差异的基础。